Therapeutic Mechanism and Efficacy of the Antibody-Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-11-0523
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII

2016English

Cryptophane Xenon-129 Nuclear Magnetic Resonance Biosensors Targeting Human Carbonic Anhydrase

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2009English

Carbonic Anhydrase IX—Mouse Versus Human

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Functional Relevance of in Vivo Half Antibody Exchange of an IgG4 Therapeutic Antibody-Drug Conjugate

PLoS ONE
Multidisciplinary
2018English

Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

Cancer Research
Cancer ResearchOncology
2016English

Extracellular Carbonic Anhydrase Activity and Carbonic Anhydrase Inhibitors in the Circulatory System of Fish

Physiological Zoology
1997English

Isolation of Human Carbonic Anhydrase B and C and Apocarbonic Anhydrase by Affinity Chromatography

Carlsberg Research Communications
1976English

Human Monoclonal Antibodies Targeting Carbonic Anhydrase IX for the Molecular Imaging of Hypoxic Regions in Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2009English

Docking Studies on Novel Human Carbonic Anhydrase Ii

International Journal of Biomedical and Advance Research
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy